ImageneBio (IMA) Other Non-Current Assets (2020 - 2025)
ImageneBio's (IMA) quarterly Other Non-Current Assets came in at $4.9 million in Q4 2025, up 378.7% year-on-year from $1.0 million in Q4 2024, and down 1.47% quarter-over-quarter from $5.0 million in Q3 2025.
ImageneBio (IMA) Other Non-Current Assets (2020 - 2025) Analysis & Trends
ImageneBio has disclosed Other Non-Current Assets across 6 years of filings, most recently posting $4.9 million for Q4 2025.
- Other Non-Current Assets for Q4 2025 came in at $4.9 million, up 378.7% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.9 million (up 378.7% YoY), and the FY2025 annual result was $4.9 million, up 378.7% from the prior year.
- Other Non-Current Assets came in at $4.9 million for Q4 2025 at ImageneBio, down from $5.0 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $24.2 million in Q2 2025 to a low of $872000.0 in Q1 2021.
- The 5-year median for Other Non-Current Assets is $3.4 million (2022), against an average of $4.6 million.
- Across the five-year window, Other Non-Current Assets plunged 81.16% in 2024 and jumped 825.11% in 2025, its largest moves.
- ImageneBio's Other Non-Current Assets stood at $2.4 million in 2021, then jumped by 58.8% to $3.8 million in 2022, then soared by 42.76% to $5.4 million in 2023, then slumped by 81.16% to $1.0 million in 2024, then soared by 378.7% to $4.9 million in 2025.
- The last three Other Non-Current Assets figures came in at $4.9 million (Q4 2025), $5.0 million (Q3 2025), and $24.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | ImageneBio | 3.18 Mn | 3.18 Mn | - | 4.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.88 Mn |
| Sep 30, 2025 | 4.95 Mn |
| Jun 30, 2025 | 24.17 Mn |
| Mar 31, 2025 | 10.23 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | 2.61 Mn |
| Jun 30, 2024 | 2.61 Mn |
| Mar 31, 2024 | 5.51 Mn |
| Dec 31, 2023 | 5.41 Mn |
| Sep 30, 2023 | 4.08 Mn |
| Jun 30, 2023 | 3.67 Mn |
| Mar 31, 2023 | 3.18 Mn |
| Dec 31, 2022 | 3.79 Mn |
| Sep 30, 2022 | 3.79 Mn |
| Jun 30, 2022 | 3.18 Mn |
| Mar 31, 2022 | 3.18 Mn |
| Dec 31, 2021 | 2.39 Mn |
| Sep 30, 2021 | 872,000.00 |
| Jun 30, 2021 | 872,000.00 |
| Mar 31, 2021 | 872,000.00 |